My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

59.70 -0.66 (-1.10%)

Streaming Delayed Price Updated: 2:24 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 5 6 Next >

GSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk

February 06, 2024

From GSK plc

Via Business Wire

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

January 24, 2024

From Elegen

Via Business Wire

GSK Enters Agreement to Acquire Aiolos Bio

January 09, 2024

From Aiolos Bio, Inc.

Via Business Wire

GlaxoSmithKline PLC (NYSE: GSK) Records 52-Week High Monday Morning

January 08, 2024

Via Investor Brand Network

GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity

December 12, 2023

From GSK plc

Via Business Wire

3 cheap 'stock'-ing stuffers Wall Street is bullish on

December 07, 2023

These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.

Via MarketBeat

Topics Stocks

These biotechs targeting multiple neurodegenerative diseases

December 01, 2023

A growing number of up-and-coming biotech firms are demonstrating the value of expanding a drug's total addressable market.

Via MarketBeat

GSK and Queer Eye’s Thom Filicia Partner on Blood Cancer Awareness Initiative

November 13, 2023

From GSK plc

Via Business Wire

GSK is a remedy for the winter investment blahs

November 07, 2023

Pharma stock GSK is a remedy for the winter blahs with a low beta, a high yield, and value for investors. Sales of new drug Arexvy underpin results.

Via MarketBeat

Topics Intellectual Property

23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK

October 30, 2023

Following their five year discovery collaboration, 23andMe and GSK have extended their collaboration by entering into a new non-exclusive data licensing agreement, enabling GSK to utilize the 23andMe...

From 23andMe, Inc.

Via GlobeNewswire

Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)

October 27, 2023

From Alector, Inc.

Via GlobeNewswire

New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease

October 25, 2023

From GSK plc

Via Business Wire

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant

September 27, 2023

By David Willey, Benzinga

Via TheNewswire.com

Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia

September 15, 2023

From GSK plc

Via Business Wire

GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations

September 05, 2023

From GSK plc

Via Business Wire

GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies

August 17, 2023

From GSK plc

Via Business Wire

Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer

July 31, 2023

From GSK plc

Via Business Wire

GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

July 13, 2023

From GSK plc

Via Business Wire

Drugmaker GSK: Becoming a Healthier Value Stock

June 27, 2023

Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit.

Via MarketBeat

Topics Lawsuit

US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making

June 21, 2023

From GSK plc

Via Business Wire

GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons

June 21, 2023

From GSK plc

Via Business Wire

GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis B

June 20, 2023

From GSK plc

Via Business Wire

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

June 08, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making...

Via FinancialNewsMedia

GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US

June 01, 2023

From GSK plc

Via Business Wire

BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition

May 16, 2023

From BELLUS Health Inc.

Via Business Wire

SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress

May 11, 2023

From SpringWorks Therapeutics, Inc.

Via GlobeNewswire

ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results

May 08, 2023

Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug

Via MarketBeat

International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

May 04, 2023

From HKTDC

Via ACN Newswire

US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults

May 03, 2023

From GSK plc

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)

May 01, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.